XOMA Royalty /
Turnstone
XOMA Royalty completes tender offer for Turnstone Biologics




Source for the buyer and target: XOMA Royalty Corporation
For the buyer and target.
“Following the closing of the tender offer, XOMA Royalty merged Turnstone with and into a subsidiary, XRA 3 Corp. (the “Merger”), and all shares of Turnstone common stock that had not been validly tendered were converted into the right to receive the Offer Price.”
Published 11 Aug 2025
Open the sourceWhat happened
XOMA Royalty Corporation completed its tender offer for Turnstone Biologics Corp. on Aug. 11, 2025. Turnstone became a wholly owned subsidiary of XOMA Royalty Corporation. [01]
Stockholders received $0.34 per share in cash plus one contingent value right. [01]
Who is involved, and the source
Everything on this page comes from the source below, quoted word for word.
Advisers
Target
- Fairness opinion to the targetLeerink PartnersSource: SEC filing, as of 11 Jul 2025
- Financial adviser to the targetLeerink PartnersSource: SEC filing, as of 11 Aug 2025
- Legal adviser to the targetCooley LLPSource: SEC filing, as of 11 Aug 2025
Each adviser in its source's own words. An adviser's own announcement is labelled as one: it is not independent reporting. Advisers are not parties to the deal.
XOMA Royalty completes tender offer for Turnstone Biologics
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“XOMA Royalty completes tender offer for Turnstone Biologics XOMA Royalty Corporation completed its tender offer for Turnstone Biologics Corp. on Aug. 11, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly